Regeneron Pharmaceuticals, Inc. and Sanofi announced positive pivotal results from a second Phase 3 trial, PRIME, evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo...
Johnson Matthey, a global leader in sustainable technologies, has launched an innovative technology – HyCOgenTM – designed to play a pivotal role in enabling...
Oramed Pharmaceuticals Inc. , a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced the European Patent Office has granted...
The Shaw Group is pleased to announce the completed acquisition of Chemex Global Inc., a premier engineering, procurement, fabrication and project management company specialized...
